Melissa S.

Melissa S. currently serves as the Director of Alliance Management and the Director of Clinical Operations and Pharmacovigilance Operations at Innoviva Specialty Therapeutics, Inc., following the acquisition of Entasis Therapeutics in May 2023. Prior to this role, Melissa held various positions at Entasis Therapeutics from March 2019 to May 2023, including Director of Clinical and Pharmacovigilance Operations and Associate Director of Pharmacovigilance Operations. Melissa's career began at PAREXEL, where roles included Project Manager and Drug Safety Associate, from 2013 to March 2019. Melissa earned a Master of Business Administration (MBA) from The University of Chicago Booth School of Business (2021-2023), a Master of Public Health (MPH) from Massachusetts College of Pharmacy and Health Sciences, and a Bachelor's degree in Physiology & Neurobiology from the University of Connecticut (2010-2014).